Hair Revival Topical

Hair Revival Topical brings together four ingredients within a single compounded topical formulation designed for application to the scalp. Minoxidil at 5% is a well-established topical agent used in the treatment of androgenetic alopecia and works by promoting blood flow to the follicle and extending the anagen (growth) phase. Finasteride at 0.5% is included for its DHT-reducing properties at the local follicle level. Caffeine and melatonin are added based on emerging research into their potential roles in scalp biology, though their contributions in compounded topical use are still being studied.

Caffeine has been investigated in vitro and in preliminary human research for potential effects on hair follicle activity, including possible influence on the growth cycle and counteraction of some testosterone-related effects at the follicle level. Melatonin, a naturally occurring hormone, has been studied in topical form for potential effects on hair cycle regulation, with some early research suggesting it may support the anagen phase. Neither ingredient should be considered a replacement for the primary active components, and the overall formulation's effect profile reflects the combination.

This product is applied topically to the scalp as prescribed by your provider. Application technique, frequency, and amount will be specified in your consultation. As with all prescription hair loss treatments, a treatment horizon of at least three to six months of consistent use is typically required before meaningful assessment of response is possible. Results, if they occur, require continued use to be maintained.

Hair Revival Topical is compounded by a licensed 503A pharmacy and is dispensed only after a licensed provider reviews your online visit. It is intended for adult individuals with androgenetic alopecia whose provider determines this formulation is appropriate. Women who are pregnant or may become pregnant should not use finasteride-containing topicals.

Potential side effects may include local scalp reactions such as irritation, redness, or dryness. Contact with non-scalp skin should be avoided to minimize the risk of unwanted hair growth. Systemic absorption of finasteride via topical application is generally lower than with oral dosing, but individual variation exists and should be discussed with your provider.